Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Moderna Therapeutics, Inc. v. Arbutus Biopharma Corporation
Case Number:
Case Type:
IPR
Status:
Final Written Decision
Petitioner:
Moderna Therapeutics, Inc.
Patent Owner:
Arbutus Biopharma Corporation
Patent Number:
Tech Center:
1600
-
July 23, 2020
Moderna Can't Invalidate Drug-Delivery Composition Patent
The Patent Trial and Appeal Board ruled Thursday that Moderna Therapeutics Inc. failed to invalidate claims in Arbutus Biopharma Corp.'s patent covering a drug-delivery composition as obvious or anticipated based on overlapping composition ranges, finding that prior art does not explicitly disclose such ranges.
-
April 22, 2020
PTAB Weighs Obviousness Standard In Gene Therapy Case
The Patent Trial and Appeal Board wrestled Wednesday with Arbutus Biopharma's argument that its rival failed to prove that claims in its patent covering a drug delivery composition are obvious on their face because their formulations overlap with those disclosed in existing technology.
-
July 25, 2019
PTAB Will Review Hep B Treatment Co.'s Patent
The Patent Trial and Appeal Board has agreed to review a drug delivery formulation patent owned by Arbutus Biopharma Corp., a company set on curing hepatitis B.